Catalyst Wire Dossier Catalyst Wire Dossier

Razadyne

Galantamine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Razadyne, covering 2017-04-28 to 2017-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease [Phase 3]

See pricing